Iovance Biotherapeutics, Inc. financial data

Symbol
IOVA on Nasdaq
Location
825 Industrial Road, 4 Th Floor, San Carlos, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 384 % -6.79%
Quick Ratio 41.7 % +143%
Debt-to-equity 28 % -0.29%
Return On Equity -52.9 % +18.7%
Return On Assets -41.3 % +18.7%
Operating Margin -170 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 362M shares +19.2%
Common Stock, Shares, Outstanding 342M shares +15%
Entity Public Float 2.1B USD +50%
Common Stock, Value, Issued 14K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 335K shares +17.4%
Weighted Average Number of Shares Outstanding, Diluted 335K shares +17.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 242M USD +92.7%
Cost of Revenue 192M USD +80.6%
Research and Development Expense 297M USD -6.36%
General and Administrative Expense 164M USD +28%
Costs and Expenses 652M USD +32.5%
Operating Income (Loss) -411M USD +10.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -390M USD +12.6%
Income Tax Expense (Benefit) 188K USD
Net Income (Loss) Attributable to Parent -390M USD +11.4%
Earnings Per Share, Basic -1 USD/shares +28%
Earnings Per Share, Diluted -1 USD/shares +28%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 132M USD -42.1%
Accounts Receivable, after Allowance for Credit Loss, Current 59.9M USD +89.7%
Inventory, Net 49.8M USD +78.9%
Assets, Current 423M USD -12.4%
Property, Plant and Equipment, Net 122M USD +10.4%
Operating Lease, Right-of-Use Asset 49.9M USD -27.7%
Other Assets, Noncurrent 10.3M USD +3055%
Assets 907M USD -5.9%
Accounts Payable, Current 32M USD +56.8%
Accrued Liabilities, Current 89.1M USD +44.2%
Liabilities, Current 129M USD +37.9%
Deferred Income Tax Liabilities, Net 34.7M USD +8.78%
Operating Lease, Liability, Noncurrent 45.1M USD -34.9%
Liabilities 209M USD +6.73%
Accumulated Other Comprehensive Income (Loss), Net of Tax 20.9M USD +3866%
Retained Earnings (Accumulated Deficit) -2.61B USD -17.5%
Stockholders' Equity Attributable to Parent 698M USD -9.12%
Liabilities and Equity 907M USD -5.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -104M USD +15.2%
Net Cash Provided by (Used in) Financing Activities 143M USD -26%
Net Cash Provided by (Used in) Investing Activities 15.9M USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 342M shares +15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 56M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 138M USD -41.1%
Deferred Tax Assets, Valuation Allowance 558M USD +24.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 575M USD +23.7%
Operating Lease, Liability 52.2M USD -35.3%
Depreciation 10.3M USD +129%
Payments to Acquire Property, Plant, and Equipment 6.21M USD +48.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -370M USD +16%
Lessee, Operating Lease, Liability, to be Paid 86.4M USD -31.2%
Property, Plant and Equipment, Gross 165M USD +13.6%
Operating Lease, Liability, Current 7.07M USD -38.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.86M USD -39.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.99M USD -64.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -1.84M USD -30.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 34.2M USD -23.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.96M USD -39.4%
Deferred Tax Assets, Operating Loss Carryforwards 303M USD +18.5%
Unrecognized Tax Benefits 29.9M USD +14.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.84M USD -42.3%
Operating Lease, Payments 17.4M USD +1.84%
Additional Paid in Capital 3.29B USD +10%
Amortization of Intangible Assets 22.2M USD +22.6%
Depreciation, Depletion and Amortization 12.2M USD +2.49%
Deferred Tax Assets, Net of Valuation Allowance 16.9M USD -3.98%